Team Uses GWAS to ID Biomarker for Hepatitis C Treatment Response

Using a data from a GWAS of almost 1,700 hepatitis C patients, researchers from Duke and Johns Hopkins University and Schering-Plough Research Institute have identified a biomarker for HCV treatment response.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.